loader
Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Alectinib Active Pharmaceutical Ingredient (API)

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Alectinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    08/10/2022 Fresenius Kabi Oncology Limited
    India
    		 M/s. Fresenius Kabi Oncology Ltd WC-0115A3 Alectinib Hydrochloride IH 2022-09-30 2025-09-15 D-35, Industrial Area, Kalyani, Dist Nadia-741 235, West Bengal 
    27/01/2024 MSN Laboratories
    India
    		 MSN Laboratories Pvt. Ltd. WC-0349 Alectinib Hydrochloride IHS 2022-09-02 2025-05-05 MIs. MSN Laboratories Private Limited, Unit-II, sv. No, 50, Kardanur (Village), Patancheru (Mandai), Sangareddy District, Telangana, 502300, India